Quanterix, Stratec Partner on Tool for Life Sciences, IVD | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular diagnostic technology firm Quanterix said today that it will work with Germany's Stratec Biomedical in a partnership to develop, manufacture, and market an automated testing tool aimed at the life sciences and medical in vitro diagnostic markets.

The companies will customize Stratec's technology to develop an automated version of Quanterix's Single Molecule Array (SiMoA) technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.